Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 37 entries
Sorted by: Best Match Show Resources per page
Phagocytosis of the protozoon Tetrahymena pyriformis as an endpoint in the estimation of cocaine salt and cocaine freebase toxicity.

Addiction biology

Stefanidou M, Alevisopoulos G, Maravelias C, Loutsidis C, Koutselinis A.
PMID: 20575814
Addict Biol. 1999 Oct;4(4):449-52. doi: 10.1080/13556219971443.

Cells of the ciliated protozoon Tetrahymena pyriformis strain W, grown in a peptone-yeast medium, usually contain many phagocytic vacuoles. The phagocytic activity of this protozoon was studied in vivo using heat-inactivated yeast stained with carmine after exposing the cultures...

Cite
Stefanidou M, Alevisopoulos G, Maravelias C, et al. Phagocytosis of the protozoon Tetrahymena pyriformis as an endpoint in the estimation of cocaine salt and cocaine freebase toxicity. Addict Biol. 1999;4(4):449-52doi: 10.1080/13556219971443.
Stefanidou, M., Alevisopoulos, G., Maravelias, C., Loutsidis, C., & Koutselinis, A. (1999). Phagocytosis of the protozoon Tetrahymena pyriformis as an endpoint in the estimation of cocaine salt and cocaine freebase toxicity. Addiction biology, 4(4), 449-52. https://doi.org/10.1080/13556219971443
Stefanidou, M, et al. "Phagocytosis of the protozoon Tetrahymena pyriformis as an endpoint in the estimation of cocaine salt and cocaine freebase toxicity." Addiction biology vol. 4,4 (1999): 449-52. doi: https://doi.org/10.1080/13556219971443
Stefanidou M, Alevisopoulos G, Maravelias C, Loutsidis C, Koutselinis A. Phagocytosis of the protozoon Tetrahymena pyriformis as an endpoint in the estimation of cocaine salt and cocaine freebase toxicity. Addict Biol. 1999 Oct;4(4):449-52. doi: 10.1080/13556219971443. PMID: 20575814.
Copy Download .nbib Format: NLM
Investigation of associations of .

Clinical ophthalmology (Auckland, N.Z.)

Sarli A, Skalidakis I, Velissari A, Koutsandrea C, Stefaniotou M, Petersen MB, Kroupis C, Kitsos G, Moschos MM.
PMID: 28794612
Clin Ophthalmol. 2017 Jul 26;11:1347-1358. doi: 10.2147/OPTH.S134538. eCollection 2017.

BACKGROUND: Age-related macular degeneration (AMD) is a multifactorial degenerative ocular disease that leads to loss of central vision. Functional gene polymorphisms have already been associated with the disease (for example, AIM: The goal of our study was to verify...

Cite
Sarli A, Skalidakis I, Velissari A, et al. Investigation of associations of . Clin Ophthalmol. 2017;11:1347-1358doi: 10.2147/OPTH.S134538.
Sarli, A., Skalidakis, I., Velissari, A., Koutsandrea, C., Stefaniotou, M., Petersen, M. B., Kroupis, C., Kitsos, G., & Moschos, M. M. (2017). Investigation of associations of . Clinical ophthalmology (Auckland, N.Z.), 111347-1358. https://doi.org/10.2147/OPTH.S134538
Sarli, Antonia, et al. "Investigation of associations of ." Clinical ophthalmology (Auckland, N.Z.) vol. 11 (2017): 1347-1358. doi: https://doi.org/10.2147/OPTH.S134538
Sarli A, Skalidakis I, Velissari A, Koutsandrea C, Stefaniotou M, Petersen MB, Kroupis C, Kitsos G, Moschos MM. Investigation of associations of . Clin Ophthalmol. 2017 Jul 26;11:1347-1358. doi: 10.2147/OPTH.S134538. eCollection 2017. PMID: 28794612; PMCID: PMC5538696.
Copy Download .nbib Format: NLM
Vascular risk factors as predictors of epilepsy in older age: The Framingham Heart Study.

Epilepsia

Stefanidou M, Himali JJ, Devinsky O, Romero JR, Ikram MA, Beiser AS, Seshadri S, Friedman D.
PMID: 34786697
Epilepsia. 2022 Jan;63(1):237-243. doi: 10.1111/epi.17108. Epub 2021 Nov 16.

OBJECTIVE: Stroke is the most common cause of epilepsy in older age. Subclinical cerebrovascular disease is believed to underlie some of the 30%-50% of late-onset epilepsy without a known cause (Li et al. Epilepsia. 1997;38:1216; Cleary et al. Lancet....

Cite
Stefanidou M, Himali JJ, Devinsky O, et al. Vascular risk factors as predictors of epilepsy in older age: The Framingham Heart Study. Epilepsia. 2021;63(1):237-243doi: 10.1111/epi.17108.
Stefanidou, M., Himali, J. J., Devinsky, O., Romero, J. R., Ikram, M. A., Beiser, A. S., Seshadri, S., & Friedman, D. (2022). Vascular risk factors as predictors of epilepsy in older age: The Framingham Heart Study. Epilepsia, 63(1), 237-243. https://doi.org/10.1111/epi.17108
Stefanidou, Maria, et al. "Vascular risk factors as predictors of epilepsy in older age: The Framingham Heart Study." Epilepsia vol. 63,1 (2022): 237-243. doi: https://doi.org/10.1111/epi.17108
Stefanidou M, Himali JJ, Devinsky O, Romero JR, Ikram MA, Beiser AS, Seshadri S, Friedman D. Vascular risk factors as predictors of epilepsy in older age: The Framingham Heart Study. Epilepsia. 2022 Jan;63(1):237-243. doi: 10.1111/epi.17108. Epub 2021 Nov 16. PMID: 34786697.
Copy Download .nbib Format: NLM
Erythrodermic Psoriasis after Rituximab Treatment in a Patient with Autoimmune Hemolytic Anemia.

Indian journal of dermatology

Koumaki D, Koumaki V, Haniotis V, Katoulis A, Boumpoucheropoulos S, Stefanidou M, Pontikoglou C, Bertsias G, Evangelou G, Zografaki K, Mantaka A, Krueger-Krasagakis SE, Krasagakis K.
PMID: 33911310
Indian J Dermatol. 2021 Jan-Feb;66(1):108-112. doi: 10.4103/ijd.IJD_336_19.

No abstract available.

Cite
Koumaki D, Koumaki V, Haniotis V, et al. Erythrodermic Psoriasis after Rituximab Treatment in a Patient with Autoimmune Hemolytic Anemia. Indian J Dermatol. 2021;66(1):108-112doi: 10.4103/ijd.IJD_336_19.
Koumaki, D., Koumaki, V., Haniotis, V., Katoulis, A., Boumpoucheropoulos, S., Stefanidou, M., Pontikoglou, C., Bertsias, G., Evangelou, G., Zografaki, K., Mantaka, A., Krueger-Krasagakis, S. E., & Krasagakis, K. (2021). Erythrodermic Psoriasis after Rituximab Treatment in a Patient with Autoimmune Hemolytic Anemia. Indian journal of dermatology, 66(1), 108-112. https://doi.org/10.4103/ijd.IJD_336_19
Koumaki, Dimitra, et al. "Erythrodermic Psoriasis after Rituximab Treatment in a Patient with Autoimmune Hemolytic Anemia." Indian journal of dermatology vol. 66,1 (2021): 108-112. doi: https://doi.org/10.4103/ijd.IJD_336_19
Koumaki D, Koumaki V, Haniotis V, Katoulis A, Boumpoucheropoulos S, Stefanidou M, Pontikoglou C, Bertsias G, Evangelou G, Zografaki K, Mantaka A, Krueger-Krasagakis SE, Krasagakis K. Erythrodermic Psoriasis after Rituximab Treatment in a Patient with Autoimmune Hemolytic Anemia. Indian J Dermatol. 2021 Jan-Feb;66(1):108-112. doi: 10.4103/ijd.IJD_336_19. PMID: 33911310; PMCID: PMC8061492.
Copy Download .nbib Format: NLM
The Influence of Curing Regimes in Self-Healing of Nano-Modified Cement Pastes.

Materials (Basel, Switzerland)

Stefanidou M, Tsardaka EC, Karozou A.
PMID: 33238635
Materials (Basel). 2020 Nov 23;13(22). doi: 10.3390/ma13225301.

The present study proposes nano-calcium oxide (NC) and nano-silica (NS) particles as healing agents in cement pastes, taking into account the curing conditions. Two series of specimens were treated in water and under wetting-drying cycles. The addition of NC...

Cite
Stefanidou M, Tsardaka EC, Karozou A. The Influence of Curing Regimes in Self-Healing of Nano-Modified Cement Pastes. Materials (Basel). 2020;13(22)doi: 10.3390/ma13225301.
Stefanidou, M., Tsardaka, E. C., & Karozou, A. (2020). The Influence of Curing Regimes in Self-Healing of Nano-Modified Cement Pastes. Materials (Basel, Switzerland), 13(22), . https://doi.org/10.3390/ma13225301
Stefanidou, Maria, et al. "The Influence of Curing Regimes in Self-Healing of Nano-Modified Cement Pastes." Materials (Basel, Switzerland) vol. 13,22 (2020). doi: https://doi.org/10.3390/ma13225301
Stefanidou M, Tsardaka EC, Karozou A. The Influence of Curing Regimes in Self-Healing of Nano-Modified Cement Pastes. Materials (Basel). 2020 Nov 23;13(22). doi: 10.3390/ma13225301. PMID: 33238635; PMCID: PMC7700502.
Copy Download .nbib Format: NLM
Adaptive immersive Virtual Environments as a treatment for depersonalization disorder.

Psychiatrike = Psychiatriki

Patrikelis P, Konstantakopoulos G, Messinis L, Alexoudi A, Stefanatou M, Nasios G, Gatzonis S.
PMID: 34390559
Psychiatriki. 2021 Aug 05; doi: 10.22365/jpsych.2021.032. Epub 2021 Aug 05.

Depersonalization is a dissociative disorder associated to a profound disruption of self-awareness in the form of emotional numbing and feelings of disembodiment. The salient feature of depersonalization is a breakdown in the familiarity of one's psychological and somatic self...

Cite
Patrikelis P, Konstantakopoulos G, Messinis L, et al. Adaptive immersive Virtual Environments as a treatment for depersonalization disorder. Psychiatriki. 2021;doi: 10.22365/jpsych.2021.032.
Patrikelis, P., Konstantakopoulos, G., Messinis, L., Alexoudi, A., Stefanatou, M., Nasios, G., & Gatzonis, S. (2021). Adaptive immersive Virtual Environments as a treatment for depersonalization disorder. Psychiatrike = Psychiatriki, . https://doi.org/10.22365/jpsych.2021.032
Patrikelis, Panayiotis, et al. "Adaptive immersive Virtual Environments as a treatment for depersonalization disorder." Psychiatrike = Psychiatriki vol. (2021). doi: https://doi.org/10.22365/jpsych.2021.032
Patrikelis P, Konstantakopoulos G, Messinis L, Alexoudi A, Stefanatou M, Nasios G, Gatzonis S. Adaptive immersive Virtual Environments as a treatment for depersonalization disorder. Psychiatriki. 2021 Aug 05; doi: 10.22365/jpsych.2021.032. Epub 2021 Aug 05. PMID: 34390559.
Copy Download .nbib Format: NLM
Trends and Key Decision Drivers For Rejecting An Orphan Drug Submission Across Five Different HTA Agencies.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Mardiguian S, Stefanidou M, Sheppard F.
PMID: 27201165
Value Health. 2014 Nov;17(7):A438. doi: 10.1016/j.jval.2014.08.1140. Epub 2014 Oct 26.

No abstract available.

Cite
Mardiguian S, Stefanidou M, Sheppard F. Trends and Key Decision Drivers For Rejecting An Orphan Drug Submission Across Five Different HTA Agencies. Value Health. 2014;17(7):A438doi: 10.1016/j.jval.2014.08.1140.
Mardiguian, S., Stefanidou, M., & Sheppard, F. (2014). Trends and Key Decision Drivers For Rejecting An Orphan Drug Submission Across Five Different HTA Agencies. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A438. https://doi.org/10.1016/j.jval.2014.08.1140
Mardiguian, S, et al. "Trends and Key Decision Drivers For Rejecting An Orphan Drug Submission Across Five Different HTA Agencies." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A438. doi: https://doi.org/10.1016/j.jval.2014.08.1140
Mardiguian S, Stefanidou M, Sheppard F. Trends and Key Decision Drivers For Rejecting An Orphan Drug Submission Across Five Different HTA Agencies. Value Health. 2014 Nov;17(7):A438. doi: 10.1016/j.jval.2014.08.1140. Epub 2014 Oct 26. PMID: 27201165.
Copy Download .nbib Format: NLM
Beware of anal fissures: pemphigus vulgaris of the anal canal.

Annals of gastroenterology

Karatzi C, Stefanidou M, Islamidou E, Kouvidou C, Chaniotis V, Evangelou G, Krueger-Krasagakis S, Athanasakis E, Krasagakis K.
PMID: 30872911
Ann Gastroenterol. 2019 Mar-Apr;32(2):205-207. doi: 10.20524/aog.2018.0340. Epub 2018 Dec 20.

A case of anal pemphigus vulgaris in a 49-year-old female suffering from pemphigus vulgaris of the oral cavity is reported. The oral manifestations were in remission until she presented with episodes of anal pain and bleeding on defecation, initially...

Cite
Karatzi C, Stefanidou M, Islamidou E, et al. Beware of anal fissures: pemphigus vulgaris of the anal canal. Ann Gastroenterol. 2018;32(2):205-207doi: 10.20524/aog.2018.0340.
Karatzi, C., Stefanidou, M., Islamidou, E., Kouvidou, C., Chaniotis, V., Evangelou, G., Krueger-Krasagakis, S., Athanasakis, E., & Krasagakis, K. (2019). Beware of anal fissures: pemphigus vulgaris of the anal canal. Annals of gastroenterology, 32(2), 205-207. https://doi.org/10.20524/aog.2018.0340
Karatzi, Chara, et al. "Beware of anal fissures: pemphigus vulgaris of the anal canal." Annals of gastroenterology vol. 32,2 (2019): 205-207. doi: https://doi.org/10.20524/aog.2018.0340
Karatzi C, Stefanidou M, Islamidou E, Kouvidou C, Chaniotis V, Evangelou G, Krueger-Krasagakis S, Athanasakis E, Krasagakis K. Beware of anal fissures: pemphigus vulgaris of the anal canal. Ann Gastroenterol. 2019 Mar-Apr;32(2):205-207. doi: 10.20524/aog.2018.0340. Epub 2018 Dec 20. PMID: 30872911; PMCID: PMC6394260.
Copy Download .nbib Format: NLM
Lymphomatoid Papulosis Type A: A Case Report of the "Wait-and-See Strategy" in a 27-Year-Old Male Patient with Extensive Disease.

Case reports in dermatological medicine

Kavvalou E, Stefanidou M, Krueger-Krasagakis SE, Evangelou G, Koumaki D, Marinos L, Tzardi M, Krasagakis K.
PMID: 31380123
Case Rep Dermatol Med. 2019 Jul 16;2019:1765210. doi: 10.1155/2019/1765210. eCollection 2019.

This is the case of a 27-year-old male patient with a newly diagnosed extensive lymphomatoid papulosis type A involving cosmetically sensitive areas (e.g. face), who refused to be treated with a low dose of methotrexate, as recommended by the...

Cite
Kavvalou E, Stefanidou M, Krueger-Krasagakis SE, et al. Lymphomatoid Papulosis Type A: A Case Report of the "Wait-and-See Strategy" in a 27-Year-Old Male Patient with Extensive Disease. Case Rep Dermatol Med. 2019;2019:1765210doi: 10.1155/2019/1765210.
Kavvalou, E., Stefanidou, M., Krueger-Krasagakis, S. E., Evangelou, G., Koumaki, D., Marinos, L., Tzardi, M., & Krasagakis, K. (2019). Lymphomatoid Papulosis Type A: A Case Report of the "Wait-and-See Strategy" in a 27-Year-Old Male Patient with Extensive Disease. Case reports in dermatological medicine, 20191765210. https://doi.org/10.1155/2019/1765210
Kavvalou, Eirini, et al. "Lymphomatoid Papulosis Type A: A Case Report of the "Wait-and-See Strategy" in a 27-Year-Old Male Patient with Extensive Disease." Case reports in dermatological medicine vol. 2019 (2019): 1765210. doi: https://doi.org/10.1155/2019/1765210
Kavvalou E, Stefanidou M, Krueger-Krasagakis SE, Evangelou G, Koumaki D, Marinos L, Tzardi M, Krasagakis K. Lymphomatoid Papulosis Type A: A Case Report of the "Wait-and-See Strategy" in a 27-Year-Old Male Patient with Extensive Disease. Case Rep Dermatol Med. 2019 Jul 16;2019:1765210. doi: 10.1155/2019/1765210. eCollection 2019. PMID: 31380123; PMCID: PMC6662440.
Copy Download .nbib Format: NLM
Red mud-molten salt composites for medium-high temperature thermal energy storage and waste heat recovery applications.

Journal of hazardous materials

Anagnostopoulos A, Navarro ME, Stefanidou M, Ding Y, Gaidajis G.
PMID: 33930958
J Hazard Mater. 2021 Jul 05;413:125407. doi: 10.1016/j.jhazmat.2021.125407. Epub 2021 Feb 17.

Red mud (RM) is an industrial waste of the aluminum industry with presently estimated worldwide legacy-site stockpiles of 4 billion tones. RM is typically disposed in the sea, dams or dykes, posing a significant environmental hazard due to its...

Cite
Anagnostopoulos A, Navarro ME, Stefanidou M, et al. Red mud-molten salt composites for medium-high temperature thermal energy storage and waste heat recovery applications. J Hazard Mater. 2021;413:125407doi: 10.1016/j.jhazmat.2021.125407.
Anagnostopoulos, A., Navarro, M. E., Stefanidou, M., Ding, Y., & Gaidajis, G. (2021). Red mud-molten salt composites for medium-high temperature thermal energy storage and waste heat recovery applications. Journal of hazardous materials, 413125407. https://doi.org/10.1016/j.jhazmat.2021.125407
Anagnostopoulos, Argyrios, et al. "Red mud-molten salt composites for medium-high temperature thermal energy storage and waste heat recovery applications." Journal of hazardous materials vol. 413 (2021): 125407. doi: https://doi.org/10.1016/j.jhazmat.2021.125407
Anagnostopoulos A, Navarro ME, Stefanidou M, Ding Y, Gaidajis G. Red mud-molten salt composites for medium-high temperature thermal energy storage and waste heat recovery applications. J Hazard Mater. 2021 Jul 05;413:125407. doi: 10.1016/j.jhazmat.2021.125407. Epub 2021 Feb 17. PMID: 33930958.
Copy Download .nbib Format: NLM
Herpes zoster viral infection after AZD1222 and BNT162b2 coronavirus disease 2019 mRNA vaccines: a case series.

Journal of the European Academy of Dermatology and Venereology : JEADV

Koumaki D, Krueger-Krasagakis SE, Papadakis M, Katoulis A, Koumaki V, Evangelou G, Stefanidou M, Mylonakis D, Zografaki K, Krasagakis K.
PMID: 34606142
J Eur Acad Dermatol Venereol. 2021 Oct 04; doi: 10.1111/jdv.17720. Epub 2021 Oct 04.

No abstract available.

Cite
Koumaki D, Krueger-Krasagakis SE, Papadakis M, et al. Herpes zoster viral infection after AZD1222 and BNT162b2 coronavirus disease 2019 mRNA vaccines: a case series. J Eur Acad Dermatol Venereol. 2021;doi: 10.1111/jdv.17720.
Koumaki, D., Krueger-Krasagakis, S. E., Papadakis, M., Katoulis, A., Koumaki, V., Evangelou, G., Stefanidou, M., Mylonakis, D., Zografaki, K., & Krasagakis, K. (2021). Herpes zoster viral infection after AZD1222 and BNT162b2 coronavirus disease 2019 mRNA vaccines: a case series. Journal of the European Academy of Dermatology and Venereology : JEADV, . https://doi.org/10.1111/jdv.17720
Koumaki, D, et al. "Herpes zoster viral infection after AZD1222 and BNT162b2 coronavirus disease 2019 mRNA vaccines: a case series." Journal of the European Academy of Dermatology and Venereology : JEADV vol. (2021). doi: https://doi.org/10.1111/jdv.17720
Koumaki D, Krueger-Krasagakis SE, Papadakis M, Katoulis A, Koumaki V, Evangelou G, Stefanidou M, Mylonakis D, Zografaki K, Krasagakis K. Herpes zoster viral infection after AZD1222 and BNT162b2 coronavirus disease 2019 mRNA vaccines: a case series. J Eur Acad Dermatol Venereol. 2021 Oct 04; doi: 10.1111/jdv.17720. Epub 2021 Oct 04. PMID: 34606142.
Copy Download .nbib Format: NLM
Adaptive immersive Virtual Environments as a treatment for depersonalization disorder.

Psychiatrike = Psychiatriki

Patrikelis P, Konstantakopoulos G, Messinis L, Alexoudi A, Stefanatou M, Nasios G, Gatzonis S.
PMID: 34390559
Psychiatriki. 2021 Dec 20;32(4):317-327. doi: 10.22365/jpsych.2021.032. Epub 2021 Aug 05.

Depersonalization is a dissociative disorder associated to a profound disruption of self-awareness in the form of emotional numbing and feelings of disembodiment. The salient feature of depersonalization is a breakdown in the familiarity of one's psychological and somatic self...

Cite
Patrikelis P, Konstantakopoulos G, Messinis L, et al. Adaptive immersive Virtual Environments as a treatment for depersonalization disorder. Psychiatriki. 2021;32(4):317-327doi: 10.22365/jpsych.2021.032.
Patrikelis, P., Konstantakopoulos, G., Messinis, L., Alexoudi, A., Stefanatou, M., Nasios, G., & Gatzonis, S. (2021). Adaptive immersive Virtual Environments as a treatment for depersonalization disorder. Psychiatrike = Psychiatriki, 32(4), 317-327. https://doi.org/10.22365/jpsych.2021.032
Patrikelis, Panayiotis, et al. "Adaptive immersive Virtual Environments as a treatment for depersonalization disorder." Psychiatrike = Psychiatriki vol. 32,4 (2021): 317-327. doi: https://doi.org/10.22365/jpsych.2021.032
Patrikelis P, Konstantakopoulos G, Messinis L, Alexoudi A, Stefanatou M, Nasios G, Gatzonis S. Adaptive immersive Virtual Environments as a treatment for depersonalization disorder. Psychiatriki. 2021 Dec 20;32(4):317-327. doi: 10.22365/jpsych.2021.032. Epub 2021 Aug 05. PMID: 34390559.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 37 entries